Authors: SCHULTZ SK MILLER DD OLIVER SE ARNDT S FLAUM M ANDREASEN NC

Citation: Sk. Schultz et al., THE LIFE-COURSE OF SCHIZOPHRENIA - AGE AND SYMPTOM DIMENSIONS, Schizophrenia research, 23(1), 1997, pp. 15-23

Authors: NOTARIANNI LJ OLIVER SE DOBROCKY P BENNETT PN SILVERMAN BW

Citation: Lj. Notarianni et al., CAFFEINE AS A METABOLIC PROBE - A COMPARISON OF THE METABOLIC RATIOS USED TO ASSESS CYP1A2 ACTIVITY (VOL 39, PG 65, 1995), British journal of clinical pharmacology, 40(1), 1995, pp. 7-7

Authors: NOTARIANNI LJ OLIVER SE DOBROCKY P BENNETT PN SILVERMAN BW

Citation: Lj. Notarianni et al., CAFFEINE AS A METABOLIC PROBE - A COMPARISON OF THE METABOLIC RATIOS USED TO ASSESS CYP1A2 ACTIVITY, British journal of clinical pharmacology, 39(1), 1995, pp. 65-69

Authors: OLIVER SE WALKER RJ WOODS DJ

Citation: Se. Oliver et al., FLUCONAZOLE INFUSED VIA A NEPHROSTOMY TUBE - A NOVEL AND EFFECTIVE ROUTE OF DELIVERY, Journal of clinical pharmacy and therapeutics, 20(6), 1995, pp. 317-318

Authors: OLIVER SE LOGAN RFA

Citation: Se. Oliver et Rfa. Logan, CANCER OF THE ESOPHAGUS, Gut, 36(1), 1995, pp. 153-153